Metabolic control of innate lymphoid cells in health and disease.

Metabolic control of innate lymphoid cells in health and disease.
复制标题

对健康和疾病中先天淋巴样细胞的代谢控制。

DOI:
10.1038/s42255-022-00685-8
复制
发表时间:
2022-12
期刊:
影响因子:
20.8
通讯作者:
Sonnenberg, Gregory F.
Sonnenberg, Gregory F.
中科院分区:
医学1区
文献类型:
--
作者:
Zhou, Lei;Lin, Qingxia;Sonnenberg, Gregory F.

文献摘要

参考文献

被引文献

相似文献

先天性淋巴样细胞(inate lymphoid cells,ILC)是一类主要存在于组织中的淋巴细胞,在哺乳动物机体的免疫、炎症、耐受和屏障表面的修复中起重要作用。ILC亚群之间的异质性与适应性CD4+ T辅助细胞对应物相当,并且新兴的研究表明,ILC生物学也由细胞代谢决定,该细胞代谢在活化、增殖或细胞因子产生期间适应生物能量需求。在小鼠模型和患者来源的样品中积累的证据表明,ILC在塑造代谢健康和疾病状态方面表现出深远的作用。在这里,我们总结和讨论我们目前的知识,控制ILC反应的细胞内源性和细胞外源性代谢因子,以及突出ILC的有机体代谢的贡献。预计这一领域的持续研究将促进我们对如何操纵ILC或其代谢以用于有益于人类健康的治疗策略的理解。先天性淋巴样细胞(ILC)是先天免疫系统的组成部分。本文综述了ILC的功能是如何调节的内在和外在的代谢途径,以及如何ILC有助于代谢疾病。
Innate lymphoid cells (ILCs) are a family of predominantly tissue-resident lymphocytes that critically orchestrate immunity, inflammation, tolerance, and repair at barrier surfaces of the mammalian body. Heterogeneity among ILC subsets is comparable to adaptive CD4+ T helper cell counterparts, and emerging studies demonstrate that ILC biology is also dictated by cellular metabolism that adapts bioenergetic requirements during activation, proliferation, or cytokine production. Accumulating evidence in mouse models and patient-derived samples indicate that ILCs exhibit profound roles in shaping states of metabolic health and disease. Here we summarize and discuss our current knowledge of the cell-intrinsic and cell-extrinsic metabolic factors controlling ILC responses, as well as highlight contributions of ILCs to organismal metabolism. It is expected that continued research in this area will advance our understanding of how to manipulate ILCs or their metabolism for therapeutic strategies that benefit human health. Innate lymphoid cells (ILCs) are an integral part of the innate immune system. This review discusses how ILC function is regulated by both intrinsic and extrinsic metabolic pathways, and how ILCs contribute to metabolic disease.
DOI: 10.1038/nm.4316
发表时间: 2017-05
期刊: Nature medicine
影响因子: 82.9
作者:
Fischer K;Ruiz HH;Jhun K;Finan B;Oberlin DJ;van der Heide V;Kalinovich AV;Petrovic N;Wolf Y;Clemmensen C;Shin AC;Divanovic S;Brombacher F;Glasmacher E;Keipert S;Jastroch M;Nagler J;Schramm KW;Medrikova D;Collden G;Woods SC;Herzig S;Homann D;Jung S;Nedergaard J;Cannon B;Tschöp MH;Müller TD;Buettner C
通讯作者: Buettner C
DOI: 10.1126/sciadv.abd0957
发表时间: 2021-01
期刊: Science advances
影响因子: 13.6
作者:
Ganesh S;Hu T;Woods E;Allam M;Cai S;Henderson W;Coskun AF
通讯作者: Coskun AF
DOI: 10.1189/jlb.0213084
发表时间: 2013-11-01
影响因子: 5.5
作者:
Bando, Jennifer K.;Nussbaum, Jesse C.;Locksley, Richard M.
通讯作者: Locksley, Richard M.
DOI: 10.1016/j.immuni.2020.02.009
发表时间: 2020-04-14
期刊: IMMUNITY
影响因子: 32.4
作者:
Flamar, Anne-Laure;Klose, Christoph S. N.;Artis, David
通讯作者: Artis, David
DOI: 10.4049/jimmunol.1600250
发表时间: 2016-10-01
影响因子: 4.4
作者:
Budda, Scott A.;Girton, Alanson;Zenewicz, Lauren A.
通讯作者: Zenewicz, Lauren A.